High SVR12 Rates in HCV Genotype 1b-Infected
Patients Receiving ABT-450/r/Ombitasvir and Dasabuvir
with or without Ribavirin Regardless of Baseline
Characteristics

dc.contributor.author	King, M.
dc.contributor.author	Moreno, C.
dc.contributor.author	Brunetto, M.R.
dc.contributor.author	Cohen, D.E.
dc.contributor.author	ÖZARAS, Reşat
dc.contributor.author	Bernstein, D
dc.contributor.author	Nevens, F
dc.contributor.author	Enejosa, JV
dc.contributor.author	Rodriguez-Perez, F.
dc.date.accessioned	2021-03-05T18:11:39Z
dc.date.available	2021-03-05T18:11:39Z
dc.identifier.citation	Bernstein D., Nevens F., Enejosa J., ÖZARAS R., Rodriguez-Perez F., Moreno C., Brunetto M., King M., Cohen D., "High SVR12 Rates in HCV Genotype 1b-Infected Patients Receiving ABT-450/r/Ombitasvir and Dasabuvir with or without Ribavirin Regardless of Baseline Characteristics", 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington D.C., Amerika Birleşik Devletleri, 5 - 09 Eylül 2014, cilt.1, no.1, ss.103
dc.identifier.other	vv_1032021
dc.identifier.other	av_c923558a-781e-4ff1-9a76-9cb5e7bf2e75
dc.identifier.uri	http://hdl.handle.net/20.500.12627/133284
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.title	High SVR12 Rates in HCV Genotype 1b-Infected Patients Receiving ABT-450/r/Ombitasvir and Dasabuvir with or without Ribavirin Regardless of Baseline Characteristics
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	1
dc.contributor.firstauthorID	656859

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.